Walvax Biotechnology Co., Ltd. (SHE: 300142)
China
· Delayed Price · Currency is CNY 17.48
-0.18 (-1.02%)
Oct 9, 2024, 3:04 PM CST
Walvax Biotechnology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 3,335 | 4,365 | 3,873 | 3,443 | 1,962 | 2,381 | Upgrade
|
| Cash & Short-Term Investments | 3,335 | 4,365 | 3,873 | 3,443 | 1,962 | 2,381 | Upgrade
|
| Cash Growth | -14.63% | 12.68% | 12.49% | 75.54% | -17.62% | -4.15% | Upgrade
|
| Accounts Receivable | 2,989 | 3,101 | 3,577 | 2,481 | 2,004 | 512.84 | Upgrade
|
| Other Receivables | 97.72 | 166.15 | 416.13 | 774.86 | 304.77 | 217.19 | Upgrade
|
| Receivables | 3,086 | 3,267 | 3,993 | 3,255 | 2,308 | 730.03 | Upgrade
|
| Inventory | 1,007 | 1,035 | 995.81 | 873.59 | 483.56 | 313.05 | Upgrade
|
| Other Current Assets | 64.61 | 67.24 | 86.25 | 107.94 | 26.77 | 19.41 | Upgrade
|
| Total Current Assets | 7,493 | 8,733 | 8,948 | 7,680 | 4,780 | 3,444 | Upgrade
|
| Property, Plant & Equipment | 3,990 | 3,768 | 3,161 | 2,604 | 1,590 | 1,389 | Upgrade
|
| Long-Term Investments | 577.1 | 1,057 | 1,292 | 1,491 | 1,605 | 862.27 | Upgrade
|
| Goodwill | 33.66 | 33.66 | 33.66 | 33.66 | 33.66 | 33.66 | Upgrade
|
| Other Intangible Assets | 1,036 | 1,086 | 1,167 | 434.98 | 271.68 | 127.04 | Upgrade
|
| Long-Term Deferred Tax Assets | 97.87 | 103.44 | 124.84 | 168.01 | 138.55 | 91.61 | Upgrade
|
| Long-Term Deferred Charges | 494.41 | 473.48 | 309.38 | 1,022 | 890 | 883.92 | Upgrade
|
| Other Long-Term Assets | 1,358 | 333.54 | 300.2 | 240.63 | 329.41 | 186.97 | Upgrade
|
| Total Assets | 15,086 | 15,589 | 15,336 | 13,674 | 9,638 | 7,018 | Upgrade
|
| Accounts Payable | 1,576 | 1,805 | 1,836 | 1,258 | 607.79 | 276.74 | Upgrade
|
| Accrued Expenses | 489.33 | 776.63 | 1,189 | 754.71 | 497.41 | 45.88 | Upgrade
|
| Short-Term Debt | 240.18 | 320.27 | 97.18 | 310 | 40 | - | Upgrade
|
| Current Portion of Long-Term Debt | 9.57 | 8.79 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 20.04 | 21.88 | 23.35 | 4.6 | - | - | Upgrade
|
| Current Income Taxes Payable | 8.69 | 14.13 | 19.47 | 2.03 | 68.54 | 32.97 | Upgrade
|
| Current Unearned Revenue | 25.77 | 42.47 | 66.78 | 35.29 | 9.68 | - | Upgrade
|
| Other Current Liabilities | 179.57 | 214.66 | 276.22 | 870.61 | 198.55 | 732.88 | Upgrade
|
| Total Current Liabilities | 2,549 | 3,204 | 3,509 | 3,235 | 1,422 | 1,088 | Upgrade
|
| Long-Term Debt | 467.98 | 434.9 | 314.24 | - | - | - | Upgrade
|
| Long-Term Leases | 11.55 | 20.6 | 27.74 | 1.06 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 288.41 | 423.33 | 404.53 | 344.3 | 256.18 | 223.14 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 66.16 | 68.71 | 90.94 | 94.56 | 112.27 | 40.16 | Upgrade
|
| Other Long-Term Liabilities | 65.99 | 42.08 | - | - | - | - | Upgrade
|
| Total Liabilities | 3,449 | 4,194 | 4,346 | 3,675 | 1,790 | 1,352 | Upgrade
|
| Common Stock | 1,605 | 1,607 | 1,607 | 1,601 | 1,546 | 1,537 | Upgrade
|
| Additional Paid-In Capital | 4,829 | 4,900 | 4,965 | 4,772 | 3,262 | 2,755 | Upgrade
|
| Retained Earnings | 3,138 | 2,984 | 2,580 | 1,895 | 1,546 | 573.19 | Upgrade
|
| Treasury Stock | -286.42 | -358.63 | -286.42 | - | - | - | Upgrade
|
| Comprensive Income & Other | 217.18 | 217.18 | 217.18 | 216.33 | 190.88 | - | Upgrade
|
| Total Common Equity | 9,504 | 9,349 | 9,084 | 8,484 | 6,545 | 4,865 | Upgrade
|
| Minority Interest | 2,133 | 2,046 | 1,906 | 1,515 | 1,303 | 800.8 | Upgrade
|
| Shareholders' Equity | 11,637 | 11,395 | 10,990 | 9,999 | 7,848 | 5,666 | Upgrade
|
| Total Liabilities & Equity | 15,086 | 15,589 | 15,336 | 13,674 | 9,638 | 7,018 | Upgrade
|
| Total Debt | 749.32 | 806.42 | 462.51 | 315.67 | 40 | - | Upgrade
|
| Net Cash (Debt) | 2,585 | 3,558 | 3,411 | 3,128 | 1,922 | 2,381 | Upgrade
|
| Net Cash Growth | -23.03% | 4.31% | 9.06% | 62.77% | -19.30% | 8.32% | Upgrade
|
| Net Cash Per Share | 1.62 | 2.22 | 2.13 | 1.99 | 1.23 | 1.55 | Upgrade
|
| Filing Date Shares Outstanding | 1,599 | 1,599 | 1,601 | 1,601 | 1,546 | 1,537 | Upgrade
|
| Total Common Shares Outstanding | 1,599 | 1,599 | 1,601 | 1,601 | 1,546 | 1,537 | Upgrade
|
| Working Capital | 4,943 | 5,529 | 5,440 | 4,445 | 3,358 | 2,355 | Upgrade
|
| Book Value Per Share | 5.94 | 5.85 | 5.67 | 5.30 | 4.23 | 3.16 | Upgrade
|
| Tangible Book Value | 8,434 | 8,230 | 7,883 | 8,016 | 6,239 | 4,704 | Upgrade
|
| Tangible Book Value Per Share | 5.27 | 5.15 | 4.92 | 5.01 | 4.04 | 3.06 | Upgrade
|
| Buildings | 954.46 | 948.5 | 767.91 | 541.68 | 487.84 | 461.58 | Upgrade
|
| Machinery | 2,118 | 2,093 | 1,580 | 1,235 | 930.76 | 744.39 | Upgrade
|
| Construction In Progress | 1,972 | 1,645 | 1,509 | 1,527 | 762.51 | 699.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.